657 completed, 49 terminated, 29 withdrawn, 20 recruiting. 367 Not applicable, 152 Phase 4, 114 Phase 3, 69 Phase 2, 17 Phase 1.
Follow Alcon Research: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cooling Eyedrops for Dry Eye TRYPTYR Eye Drops, Purilens Plus Non-Preserved Saline Eye Drops - Dry Eye | Phase 4 | Not yet recruiting | University of California, Berkeley | 50 | 2026-11-01 | 2026-10-26 |
| Evaporative Dry Eye acoltremon 0.003%. - Dry Eye, Evaporative Dry Eye | Phase 4 | Not yet recruiting | Southern College of Optometry | 41 | 2026-10-26 | 2026-10-28 |
| Clinical Evaluation of a Novel Trifocal IOL LPYWT0, PXYWT0, Cataract Surgery - Aphakia, Cataract | Not applicable | Recruiting | Alcon Research | 66 | 2026-10-09 | 2026-10-21 |
| Effect of Acoltremon Ophthalmic Solution 0.003% on Tear Production and Symptoms in Patients With Tear Deficiency and Concurrent Neuropathic Corneal Pain acoltremon ophthalmic solution 0.003% - Ocular Pain, Dry Eye | Phase 4 | Not yet recruiting | University of South Florida | 28 | 2026-10-01 | 2026-10-06 |
| Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma Patients Netarsudil 0.02% Ophthalmic Solution [RHOPRESSA], Timolol Maleate 0.25% Ophthalmic Solution - Open Angle Glaucoma (OAG), Glaucoma | Phase 4 | Recruiting | Brett King | 13 | 2026-10-01 | 2026-10-28 |
| Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free, Vehicle - Ocular Hyperemia | Phase 3 | Recruiting | Alcon Research | 230 | 2026-09-30 | 2026-10-16 |
| An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free, Vehicle - Ocular Hyperemia | Phase 3 | Recruiting | Alcon Research | 178 | 2026-09-27 | 2026-11-12 |
| UNITY DX Cornea Study UNITY DX, ANTERION - Tomography | Recruiting | Alcon Research | 110 | 2026-09-24 | 2026-11-12 | |
| Agreement of Two OCT Biometers: A Pilot Study UNITY DX, ANTERION - Anterior Segment of Eye, Axial Length | Recruiting | Alcon Research | 50 | 2026-08-17 | 2026-09-02 | |
| Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects Rocklatan (Netarsudil 0.02%/ latanoprost 0.005), Latanoprost (0.005%) - Ocular Hypertension, Suspect Glaucoma | Phase 4 | Recruiting | University of Maryland, Baltimore | 50 | 2026-07-02 | 2026-07-02 |
| Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular Hypertension Netarsudil Ophthalmic Solution (Rhopressa), Artificial Tears (AT) - Glaucoma, Ocular Hypertension | Phase 4 | Recruiting | Indiana University | 50 | 2026-06-05 | 2026-06-11 |
| Evaluation of Tears Naturale® Free and Tears Naturale® II Lubricant Eye Drops Tears Naturale Free lubricating eye drops, Tears Naturale II lubricating eye drops - Dry Eye Disease | Not applicable | Completed | Alcon Research | 132 | 2026-06-04 | 2026-10-07 |
| P1 Toric Vs. Max 1day , silicone hydrogel (lehfilcon A) soft contact lens (CL) with SMARTSURFACE Technology and UV protection - Eye, Astigmatism | Not applicable | Active not recruiting | Southern College of Optometry | 32 | 2026-05-27 | 2026-11-04 |
| Clareon TruPlus Study Clareon TruPlus Monofocal Non-Toric IOL, Clareon TruPlus Monofocal Toric IOL, Phacoemulsification - Aphakia, Astigmatism | Not applicable | Recruiting | Alcon Research | 185 | 2026-05-26 | 2026-10-30 |
| Refitting Satisfied INFUSE One-Day Multifocal Wearers to DAILIES TOTAL1 Multifocal Contact Lenses DAILIES TOTAL1 Multifocal (delefilcon A) - Contact Lens Comfort and Successful Refitting, Presbyopia | Not applicable | Recruiting | Gordon Schanzlin New Vision | 30 | 2026-05-20 | 2026-06-11 |
| Contralateral Claims Study of Clareon Vivity Pro Clareon Vivity Pro IOL, Clareon Vivity IOL, TECNIS PureSee IOL - Aphakia, Presbyopia | Not applicable | Active not recruiting | Alcon Research | 165 | 2026-04-28 | 2026-11-09 |
| Wear Experience With Daily Disposable Contact Lenses for Astigmatism Over a Long-Wear Day Daily disposable contact lenses for astigmatism - Astigmatism | Not applicable | Recruiting | Ohio State University | 40 | 2026-03-04 | 2026-09-25 |
| An Evaluation of the Safety and Tolerability of Ocular Lubricants FID123440 test formulation, FID123437 test formulation - Dry Eye Disease | Not applicable | Completed | Alcon Research | 124 | 2026-03-04 | 2026-08-11 |
| Comparison of Ocular Lubricants in People With Symptoms of Dry Eye Propylene glycol 0.6%, 3% trehalose and 0.15% sodium hyaluronate - Dry Eye Symptoms | Phase 4 | Completed | University of Waterloo | 36 | 2026-02-23 | 2026-09-01 |
| SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease SYSTANE® PRO, MIEBO™ (Perfluorohexyloctane, PFHO) - Dry Eye Disease (DED) | Phase 4 | Completed | Indiana University | 269 | 2026-02-18 | 2026-08-19 |
Showing 20 of 782. Sign in to see all of them.
Cataract (138) · Glaucoma, Open-Angle (116) · Dry Eye Syndromes (113) · Ocular Hypertension (112) · Refractive Errors (103) · Glaucoma (102) · Myopia (97) · Astigmatism (62) · Presbyopia (41) · Hyperopia (27) · Aphakia (24) · Macular Degeneration (22) · Conjunctivitis, Allergic (21) · Hypertension (17) · Conjunctivitis (9)
Travoprost (66) · Ophthalmic Solutions (49) · brinzolamide (38) · Timolol (32) · Latanoprost (29) · Cataract Extraction (25) · anecortave acetate (25) · Duotrav (19) · Olopatadine Hydrochloride (19) · Brimonidine Tartrate (16) · Dexamethasone (14) · Azarga (13) · Contact Lenses (11) · Lubricant Eye Drops (10) · Moxifloxacin (10)
United States (392) · Canada (31) · Australia (21) · Japan (19) · United Kingdom (18) · Spain (13) · India (10) · Germany (9) · China (8) · France (8) · Brazil (7) · Italy (6) · South Korea (5) · Taiwan (5) · Netherlands (4)
Abayomi Ogundele, PharmD (6) · Joachim Nick, Dipl. Ing. (6) · Lawrence A. Yannuzzi, MD (6) · Lyndon Jones, PhD, FCOptom (6) · Theresa Landry (6)
PMID 21681652, PMID 21750611, PMID 27388251, PMID 27466061, PMID 30986442, PMID 32600261, PMID 33207259, PMID 34968756, PMID 35749069, PMID 39033924, PMID 42210509, PMID 11589866, PMID 14508260, PMID 14736774, PMID 14996520, PMID 16196117, PMID 17191187, PMID 17415690, PMID 18289898, PMID 18414108, PMID 18500088, PMID 18538406, PMID 18695101, PMID 18703943, PMID 18826749, PMID 19049301, PMID 19084273, PMID 19157559, PMID 19365194, PMID 19426959, PMID 19506189, PMID 19668532, PMID 19668762, PMID 19683191, PMID 20065212, PMID 20457949, PMID 20505839, PMID 20592230, PMID 20631232, PMID 20688734, PMID 21048504, PMID 21138337, PMID 21310379, PMID 21477426, PMID 21498612, PMID 21704965, PMID 21724047, PMID 21773673, PMID 21925737, PMID 22084157
2005 (2), 2008 (2), 2014 (2), 2016 (2), 2015 (1), U10EY013272 (1)